4D Molecular Therapeutics exchanges 6.6M shares for pre-funded warrants with RA Capital and BVF

4D Molecular Therapeutics, Inc.

RA Capital exchanged 4,850,000 shares for a warrant to acquire 4,850,000 shares.
BVF exchanged 1,750,000 shares for a warrant to acquire 1,750,000 shares.
Post-exchange shares outstanding as of Jan 23, 2026: 51,007,874; warrants exercisable for 16,935,665 total shares.
Warrants have $0.0001 exercise price, no expiration, and 4.99%/9.99% beneficial ownership blocker.
Issued in reliance on Section 3(a)(9) exemption from registration.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

4D Molecular Therapeutics, Inc. issued 4,850,000 shares of warrant to RA Capital Healthcare Fund, L.P. for exchanged 4,850,000 shares of the Company's common stock for a pre-funded warrant.

Security: warrant
Shares: 4,850,000 shares
Purchaser: RA Capital Healthcare Fund, L.P.
Consideration: exchanged 4,850,000 shares of the Company's common stock for a pre-funded warrant

Exact text from the filing

pursuant to which RA Capital exchanged 4,850,000 shares of the Company’s common stock for a pre-funded warrant to acquire 4,850,000 shares of the Company’s common stock

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

4D Molecular Therapeutics, Inc. issued 1,750,000 shares of warrant to Biotechnology Value Fund, L.P. and its affiliates for exchanged 1,750,000 shares of the Company's common stock for a pre-funded warrant.

Security: warrant
Shares: 1,750,000 shares
Purchaser: Biotechnology Value Fund, L.P. and its affiliates
Consideration: exchanged 1,750,000 shares of the Company's common stock for a pre-funded warrant

Exact text from the filing

BVF exchanged 1,750,000 shares of the Company’s common stock for a pre-funded warrant to acquire 1,750,000 shares of the Company’s common stock

View on SEC.gov

Browse all equity issuances →

4D Molecular Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-022559

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.